Registration for a live webinar on 'Innovative Vaccines and Viral Pathogenesis: Insights from Recent Monkeypox Research' is now open.
See webinar detailsWe noted you are experiencing viewing problems
-
Check with your IT department that JWPlatform, JWPlayer and Amazon AWS & CloudFront are not being blocked by your network. The relevant domains are *.jwplatform.com, *.jwpsrv.com, *.jwpcdn.com, jwpltx.com, jwpsrv.a.ssl.fastly.net, *.amazonaws.com and *.cloudfront.net. The relevant ports are 80 and 443.
-
Check the following talk links to see which ones work correctly:
Auto Mode
HTTP Progressive Download Send us your results from the above test links at access@hstalks.com and we will contact you with further advice on troubleshooting your viewing problems. -
No luck yet? More tips for troubleshooting viewing issues
-
Contact HST Support access@hstalks.com
-
Please review our troubleshooting guide for tips and advice on resolving your viewing problems.
-
For additional help, please don't hesitate to contact HST support access@hstalks.com
We hope you have enjoyed this limited-length demo
This is a limited length demo talk; you may
login or
review methods of
obtaining more access.
Printable Handouts
Navigable Slide Index
- Introduction
- Talk outline
- Variceal bleeding
- Varices increase in diameter progressively
- Beta blocker prevention of first variceal hemorrhage
- Variceal hemorrhage
- Variceal bleeding pearls
- Ascites
- Ascites management
- Hepatorenal syndrome
- Hepatorenal survival
- HRS treatment
- Vasoconstrictors and HRS
- West Haven classification of HE
- Precipitants of HE
- Rifaximin vs. nonabsorbable disaccharides
- Hepatopulmonary syndrome
- Hepatopulmonary syndrome survival rate
- Transplantation outcome in HPS patients
- Portopulmonary hypertension
- PPHTN: liver transplantation
- Evaluation/preparation for liver transplantation (1)
- Evaluation/preparation for liver transplantation (2)
- Alcohol and transplantation
- Hepatitis B
- Hepatitis C treatment prior to transplantation
- NASH/metabolic syndrome
- Liver transplantation for HCC: Milan criteria
- UCSF criteria for HCC
- Listing criteria for liver transplantation
- Liver allocation MELD score
- Mortality risk according to MELD
- Change to inactive status
- Medical conditions after liver transplantation
- Biliary endoscopy
- Fluoroscopic view of ERCP: anastomotic strictures
- Fluoroscopic view of ERCP: biliary leaks
- Biliary casts - endoscopy
- GI related disorders
- Inflammatory bowel disease
- Colon cancer, IBD, PSC and transplantation
- Annual examinations
- Vaccination
- Obesity
- Bone disease
- Bone disease recommendations
- Cardiovascular disease
- Cardiovascular recommendations
- Diabetes
- Patient/graft survival in patients with or W/O DM
- CRF after solid organ transplantation
- Renal disease
- De novo malignancy
- Long-term causes of death
- Drug interactions in transplantation medications
- Future prospects
Topics Covered
- Common complications of end stage cirrhosis including life threatening disorders of variceal bleeding, ascites, hepatorenal syndrome, encephalopathy and hepatopulmonary syndrome
- Preparation for listing for liver transplantation in patients with end stage liver disease includes documentation and absence of alcohol consumption (in alcoholics), reduction of hepatitis B DNA levels (in HBV patients) and aggressive treatment of hepatocellular carcinoma to reduce the risk of recurrent disease
- The most common allocation system for liver transplantation is the model for end stage liver disease
- Post transplantation care of the patient requires diligent annual followup with concentration on common diseases which include: metabolic syndrome (diabetes mellitus, obesity, hypertension, hyperlipidemia), Preventive medicine (vaccination, dental disease), Inflammatory bowel disease, bone disease, and renal dysfunction
Links
Series:
Categories:
Therapeutic Areas:
Talk Citation
McCashland, T.M. (2011, January 5). The management of other aspects of chronic liver disease, including transplantation [Video file]. In The Biomedical & Life Sciences Collection, Henry Stewart Talks. Retrieved November 2, 2024, from https://doi.org/10.69645/JATB8280.Export Citation (RIS)
Publication History
Financial Disclosures
- Prof. Timothy M. McCashland has not informed HSTalks of any commercial/financial relationship that it is appropriate to disclose.
The management of other aspects of chronic liver disease, including transplantation
A selection of talks on Gastroenterology & Nephrology
Hide